Studies have reported that miR-BART8-3p was highly expressed in NPC patients, and it promoted metastasis and radioresistance by regulating NF-κB and Erk1/2 and ATM/ATR signaling pathway, highlighting its promising value as a biomarker13,21. This evidence concerns the gene MAPK3 and nasopharyngeal carcinoma.